Concepedia

Chi Shing Sum

CS

20

Publications

829

Citations

15

H-Index

2001

Active since

Affiliations

Bristol-Myers Squibb (United States)(Current)

University of Toronto

Emory University

National Institutes of Health

National Institute of Diabetes and Digestive and Kidney Diseases

Chi Shing Sum is an author at Bristol-Myers Squibb (United States) specializing in medicine, signal transduction, and molecular physiology.

Top concepts

Publications per year

2001–2022

20

Publications

20

Discovery of Novel Agonists and Antagonists of the Free Fatty Acid Receptor 1 (FFAR1) Using Virtual Screening

Irina G. Tikhonova, Chi Shing Sum, Susanne Neumann et al. · Journal of Medicinal Chemistry · 2008 · 147 citations · Full text

Identification of Residues Important for Agonist Recognition and Activation in GPR40

Chi Shing Sum, Irina G. Tikhonova, Susanne Neumann et al. · Journal of Biological Chemistry · 2007 · 120 citations · Full text

Bidirectional, Iterative Approach to the Structural Delineation of the Functional “Chemoprint” in GPR40 for Agonist Recognition

Irina G. Tikhonova, Chi Shing Sum, Susanne Neumann et al. · Journal of Medicinal Chemistry · 2007 · 87 citations · Full text

Two Arginine-Glutamate Ionic Locks Near the Extracellular Surface of FFAR1 Gate Receptor Activation

Chi Shing Sum, Irina G. Tikhonova, Stefano Costanzi et al. · Journal of Biological Chemistry · 2008 · 58 citations · Full text

, , +12

Discovery of an Oxycyclohexyl Acid Lysophosphatidic Acid Receptor 1 (LPA<sub>1</sub>) Antagonist BMS-986278 for the Treatment of Pulmonary Fibrotic Diseases

Peter T. W. Cheng, Robert F. Kaltenbach, Hao Zhang et al. · Journal of Medicinal Chemistry · 2021 · 53 citations · Full text

Rows per page

1–5 of 20